Biodesix Stockholders to Sell 62.2 Million Shares; Files $250 Million Mixed-Shelf Offering

MT Newswires Live

Nov 01, 2024

Biodesix (BDSX) said in a regulatory filing Friday that some stockholders are selling up to 62.2 million of their shares.

The selling stockholders include entities related to Biodesix's board directors: Westwood Management's chief executive officer Lawrence Kennedy Jr., Crabtree Partners' co-founders Jack Schuler and John Patience, as well as Birchview Capital's managing partner Matthew Strobeck, the filing showed.

Biodesix said it will not receive any proceeds from the sale.

Separately, Biodesix filed a registration statement to sell up to $250 million in securities from time to time.

The filing includes the sale of the company's common stock, preferred stock, warrants and units, as well as rights to purchase these securities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2480885578"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2480885578\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2480885578?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-01 21:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2480885578","market":"fut","top_or_hot":-1,"title":"Biodesix Stockholders to Sell 62.2 Million Shares; Files $250 Million Mixed-Shelf Offering","media":"MT Newswires Live","content":"<html><body><p> Biodesix (BDSX) said in a regulatory filing Friday that some stockholders are selling up to 62.2 million of their shares.</p><p>The selling stockholders include entities related to Biodesix's board directors: Westwood Management's chief executive officer Lawrence Kennedy Jr., Crabtree Partners' co-founders Jack Schuler and John Patience, as well as Birchview Capital's managing partner Matthew Strobeck, the filing showed.</p><p>Biodesix said it will not receive any proceeds from the sale.</p><p>Separately, Biodesix filed a registration statement to sell up to $250 million in securities from time to time.</p><p>The filing includes the sale of the company's common stock, preferred stock, warrants and units, as well as rights to purchase these securities.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biodesix Stockholders to Sell 62.2 Million Shares; Files $250 Million Mixed-Shelf Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiodesix Stockholders to Sell 62.2 Million Shares; Files $250 Million Mixed-Shelf Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-11-01 21:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Biodesix (BDSX) said in a regulatory filing Friday that some stockholders are selling up to 62.2 million of their shares.</p><p>The selling stockholders include entities related to Biodesix's board directors: Westwood Management's chief executive officer Lawrence Kennedy Jr., Crabtree Partners' co-founders Jack Schuler and John Patience, as well as Birchview Capital's managing partner Matthew Strobeck, the filing showed.</p><p>Biodesix said it will not receive any proceeds from the sale.</p><p>Separately, Biodesix filed a registration statement to sell up to $250 million in securities from time to time.</p><p>The filing includes the sale of the company's common stock, preferred stock, warrants and units, as well as rights to purchase these securities.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4196","symbol_name":"保健护理服务","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2480885578","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2480885578","pubTimestamp":1730466794,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Biodesix  said in a regulatory filing Friday that some stockholders are selling up to 62.2 million of their shares.The selling stockholders include entities related to Biodesix's board directors: Westwood Management's chief executive officer Lawrence Kennedy Jr., Crabtree Partners' co-founders Jack Schuler and John Patience, as well as Birchview Capital's managing partner Matthew Strobeck, the filing showed.Biodesix said it will not receive any proceeds from the sale.Separately, Biodesix filed a registration statement to sell up to $250 million in securities from time to time.The filing includes the sale of the company's common stock, preferred stock, warrants and units, as well as rights to purchase these securities.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4196":"保健护理服务","BDSX":"Biodesix, Inc."},"translate_title":"Biodesix股东将出售6220万股；提交2.5亿美元的混合货架发行","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BDSX":1},"content_text":"Biodesix (BDSX) said in a regulatory filing Friday that some stockholders are selling up to 62.2 million of their shares.The selling stockholders include entities related to Biodesix's board directors: Westwood Management's chief executive officer Lawrence Kennedy Jr., Crabtree Partners' co-founders Jack Schuler and John Patience, as well as Birchview Capital's managing partner Matthew Strobeck, the filing showed.Biodesix said it will not receive any proceeds from the sale.Separately, Biodesix filed a registration statement to sell up to $250 million in securities from time to time.The filing includes the sale of the company's common stock, preferred stock, warrants and units, as well as rights to purchase these securities.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}